Influence, Integrity, and the FDA: An Ethical Framework

Hey SP, Cohen IG, Adashi EY, Kesselheim AS - Science

  • Regulation and Clinical Evidence

Summary:

The authors present an ethical decision framework for distinguishing between legitimate external influences that serve the FDA’s regulatory mission and illegitimate influences that corrupt or undermine the agency’s scientific deliberations. The framework is designed to assist regulators, policymakers, judges, physicians, and the public in evaluating whether external pressures on FDA decisions appropriately advance public health or compromise the agency’s core mission of ensuring drug and device safety and efficacy based on scientific evidence.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
An icon of a bill representing government policy.

Comments on FDA Discussion Paper, “Considerations for the Regulation of Generative AI-Enabled Medical Devices”

Jaiswal N, Gorijavolu R, Thomas S, Hwang TJ, Celi LA, Kesselheim AS - Food and Drug Administration (FDA)

  • Regulation and Clinical Evidence